iShares Biotechnology ETF
583 hedge funds and large institutions have $6.44B invested in iShares Biotechnology ETF in 2017 Q3 according to their latest regulatory filings, with 78 funds opening new positions, 212 increasing their positions, 173 reducing their positions, and 52 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
4% more funds holding
Funds holding: 561 → 583 (+22)
9% less funds holding in top 10
Funds holding in top 10: 33 → 30 (-3)
22% less call options, than puts
Call options by funds: $810M | Put options by funds: $1.04B
Holders
583
Holding in Top 10
30
Calls
$810M
Puts
$1.04B
Top Buyers
| 1 | +$966M | |
| 2 | +$135M | |
| 3 | +$99.1M | |
| 4 |
Goldman Sachs
New York
|
+$90.8M |
| 5 |
Jane Street
New York
|
+$53.9M |
Top Sellers
| 1 | -$281M | |
| 2 | -$105M | |
| 3 | -$93M | |
| 4 |
AL
Appaloosa LP
Short Hills,
New Jersey
|
-$72.9M |
| 5 |
QIM
Quantitative Investment Management
Charlottesville,
Virginia
|
-$71.6M |